Response to Hyun J.W. et al. “Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis”

Abstract

Get full access to this article

View all access options for this article.

References

Hyun

Kim

, et al. Longitudinal analysis of serum neurofilament light chain: A potential therapeutic monitoring biomarker for multiple sclerosis. Mult Scler 2020; 26(6): 659–667.

Disanto

Barro

Benkert

, et al. Serum neurofilament light: A biomarker of neuronal damage in multiple sclerosis. Ann Neurol 2017; 81: 857–870.

Kuhle

Kropshofer

Haering

, et al. Blood neurofilament light chain as a biomarker of MS disease activity and treatment response. Neurology. Epub ahead of print 8 February 2019. DOI: 10.1212/WNL.0000000000007032.

Akgün

Kretschmann

Haase

, et al. Profiling individual clinical responses by high-frequency serum neurofilament assessment in MS. Neurol Neuroimmunol Neuroinflamm. Epub ahead of print 8 April 2019. DOI: 10.1212/NXI.0000000000000555.